Similar articles

• Neuroleptic malignant syndrome related to use of clozapine.

  Trayer JS, Fidler DC. Trayer JS, et al. J Am Osteopath Assoc. 1998 Mar;98(3):168-9. J Am Osteopath Assoc. 1998. PMID: 9558834
• Clozapine-induced neuroleptic malignant syndrome: clozapine monotherapy rechallenge in a case of previous NMS.

  Illing M, Ancill R. Illing M, et al. Can J Psychiatry. 1996 May;41(4):258. Can J Psychiatry. 1996. PMID: 8726793 No abstract available.
• Neuroleptic-resistant schizophrenia treated with clozapine and ECT.

  Benatov R, Sirota P, Megged S. Benatov R, et al. Convuls Ther. 1996 Jun;12(2):117-21. Convuls Ther. 1996. PMID: 8744173
• [Neuroleptic malignant syndrome. Case reports].

  Berardi D, Troia M, Veronesi L, Ferrari G. Berardi D, et al. Minerva Psichiatr. 1994 Dec;35(4):199-219. Minerva Psichiatr. 1994. PMID: 7861943 Review. Italian.
• Pharmacologic treatment of schizophrenia.

  Levinson DF. Levinson DF. Clin Ther. 1991 May-Jun;13(3):326-52. Clin Ther. 1991. PMID: 1683269 Review.